We are live on ! Find out more
SS

Steve Schonfeld Schonfeld Strategic Advisors

AUM $27.9B
1-Year Est. Return 51.18%
 

Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+51.18%
3 Year Est. Return
+146.2%
5 Year Est. Return
+181.83%
10 Year Est. Return
+1,776.88%
AUM
$1.22B
AUM Growth
+$126M
Cap. Flow
+$160M
Cap. Flow %
13.12%
Top 10 Hldgs %
9.33%
Holding
998
New
433
Increased
145
Reduced
138
Closed
273

Sector Composition

Rank Sector Weight
1 Healthcare 24.17%
2 Consumer Discretionary 17.86%
3 Industrials 12.79%
4 Financials 9.03%
5 Technology 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
F icon
676
CALL
Ford
F
$57.5B
$194K 0.02%
+900,000
New +$11.1M
KHC icon
677
Kraft Heinz
KHC
$30.3B
$185K 0.02%
2,380
-15,437
-87% -$1.21M
CCJ icon
678
Cameco
CCJ
$44.6B
$182K 0.01%
19,712
-37,040
-65% -$347K
KW
679
DELISTED
Kennedy-Wilson Holdings
KW
$178K 0.01%
+10,261
New +$193K
CTRE icon
680
CareTrust REIT
CTRE
$9.35B
$176K 0.01%
+10,494
New +$194K
FNKO icon
681
Funko
FNKO
$364M
$174K 0.01%
+26,237
New +$202K
CISN
682
DELISTED
Cision Ltd. Ordinary Share
CISN
$174K 0.01%
+14,683
New +$181K
THC icon
683
Tenet Healthcare
THC
$22.6B
$170K 0.01%
+11,195
New +$158K
VTLE
684
DELISTED
Vital Energy
VTLE
$164K 0.01%
+771
New +$169K
CNX icon
685
CNX Resources
CNX
$5.38B
$158K 0.01%
+10,800
New +$149K
KEM
686
DELISTED
KEMET Corporation
KEM
$155K 0.01%
+10,295
New +$196K
CVE icon
687
Cenovus Energy
CVE
$60.7B
$154K 0.01%
+16,817
New +$163K
CPRX
688
DELISTED
Catalyst Pharmaceutical
CPRX
$153K 0.01%
+38,997
New +$129K
PBR.A icon
689
Petrobras Class A
PBR.A
$111B
$150K 0.01%
+15,233
New +$150K
GPRO icon
690
GoPro
GPRO
$116M
$135K 0.01%
+17,897
New +$159K
ARRY
691
DELISTED
Array Biopharma Inc
ARRY
$129K 0.01%
+10,055
New +$114K
QQQ icon
692
PUT
Invesco QQQ Trust
QQQ
$486B
$125K 0.01%
+50,000
New +$7.63M
PRDO icon
693
Perdoceo Education
PRDO
$2.07B
$123K 0.01%
+10,209
New +$121K
HIMX
694
Himax Technologies
HIMX
$2.41B
$121K 0.01%
+11,661
New +$127K
TAHO
695
DELISTED
Tahoe Resources Inc
TAHO
$120K 0.01%
+25,072
New +$118K
BKD icon
696
Brookdale Senior Living
BKD
$2.82B
$117K 0.01%
12,056
-6,358
-35% -$64.8K
KHC icon
697
CALL
Kraft Heinz
KHC
$30.3B
$117K 0.01%
60,000
-65,000
-52% -$5.11M
AUD
698
DELISTED
Audacy, Inc.
AUD
$116K 0.01%
+10,730
New +$122K
CSR
699
Centerspace
CSR
$906M
$112K 0.01%
+1,964
New +$117K
PBR icon
700
Petrobras
PBR
$123B
$107K 0.01%
+10,341
New +$106K

Similar funds

Steve Schonfeld's Q4 2017 Portfolio in Review

As of Q4 2017, Steve Schonfeld held 998 positions worth $1.22B, up 12% from $1.1B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Steve Schonfeld deployed $160M of net new capital in Q4 2017, opening 433 new positions and adding to 145 existing holdings. Its largest new stake was State Street SPDR S&P MIDCAP 400 ETF Trust: 29,148 shares worth $10.1M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Aetna Inc, an estimated $12.6M trimmed.

  • Steve Schonfeld's largest Q4 2017 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 29,148 shares worth $10.1M.
  • Steve Schonfeld added most to Dollar Tree in Q4 2017, an estimated $8.78M increase.
  • Steve Schonfeld's biggest Q4 2017 reduction was Aetna Inc, cutting an estimated $12.6M.
  • Steve Schonfeld fully exited First Data Corporation in Q4 2017, selling an estimated $14.8M.
  • Steve Schonfeld's ten largest holdings make up 9.3% of its $1.22B portfolio in Q4 2017.
  • Steve Schonfeld opened 433 new positions and closed 273 in Q4 2017.
  • Steve Schonfeld's portfolio value rose 12% quarter-over-quarter to $1.22B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.